Finasteride reduces cancer risk, does not increase death risk
نویسندگان
چکیده
منابع مشابه
Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach.
Finasteride taken for 7 years in the Prostate Cancer Prevention Trial (PCPT) reduced the risk of prostate cancer by 25%, but with an apparent increased risk of high-grade disease. Subsequent analyses found that finasteride biases toward improved prostate cancer detection and accuracy in prostate cancer grading at biopsy. In our first analysis of the present study, we accounted for these biases ...
متن کاملCancer Prevention Research Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling Approach
Finasteride taken for 7 years in the Prostate Cancer Prevention Trial (PCPT) reduced the risk of prostate cancer by 25%, but with an apparent increased risk of high-grade disease. Subsequent analyses found that finasteride biases toward improved prostate cancer detection and accuracy in prostate cancer grading at biopsy. In our first analysis of the present study, we accounted for these biases ...
متن کاملHuman Insulin Does Not Increase Bladder Cancer Risk
BACKGROUND Whether human insulin can induce bladder cancer is rarely studied. METHODS The reimbursement databases of all Taiwanese diabetic patients from 1996 to 2009 were retrieved from the National Health Insurance. An entry date was set at 1 January 2004 and a total of 785,234 patients with type 2 diabetes were followed up for bladder cancer incidence until the end of 2009. Users of piogli...
متن کاملActivated Protein C Resistance Does Not Increase Risk for Recurrent Stroke or Death in Stroke Patients
BACKGROUND Activated protein C (APC) resistance is the most common inherited prothrombotic disorder. The role of APC resistance in ischemic stroke is controversially discussed. OBJECTIVES The aim of this single center follow up study was to investigate the effect of APC resistance on stroke recurrence and survival in stroke patients. PATIENTS/METHODS We retrospectively identified 966 patien...
متن کاملFinasteride reduces the risk of incident clinical benign prostatic hyperplasia.
BACKGROUND Despite the high prevalence of clinical benign prostatic hyperplasia (BPH) among older men, there remains a notable absence of studies focused on BPH prevention. OBJECTIVE To determine if finasteride prevents incident clinical BPH in healthy older men. DESIGN, SETTING, AND PARTICIPANTS Data for this study are from the Prostate Cancer Prevention Trial. After excluding those with a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 2013
ISSN: 0008-543X
DOI: 10.1002/cncr.28457